The clinical efficacy of fibrinogen concentrate in massive obstetric haemorrhage with hypofibrinogenaemia

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Matsunaga, Shigetaka ^a   Takai, Yasushi ^a   Nakamura, Eishin ^a   Era, Sumiko ^a   Ono, Yoshihisa ^a   Yamamoto, Koji ^a   Maeda, Hiroo ^a   Seki, Hiroyuki ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; BLEEDING; BLOOD CLOTTING DISORDER; COMPLICATION; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; COAGULATION PROTEIN DISORDERS; FEMALE; FIBRINOGEN; HEMORRHAGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85038953244     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46749     Document Type: Article

References (31)

1. Say, L. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health. 2, e323-333 (2014).
2. Charbit, B. et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J. Thromb. Haemost. 5, 266-273 (2007).
3. McLintock, C. & James, A. H. Obstetric hemorrhage. J Thromb Haemost. 9, 1441-1451 (2011).
4. Matsunaga, S. et al. A retrospective analysis of transfusion management for obstetric hemorrhage in a Japanese obstetric center. ISRN. Obstet. Gynecol. 2012, 854064 (2012).
5. Era, S., Matsunaga, S., Matsumura, H., Murayama, Y., Takai, Y. & Seki, H. Usefulness of shock indicators for determining the need for blood transfusion after massive obstetric hemorrhage. J Obstet Gynaecol Res. 41, 39-43 (2015).
6. de Lloyd, L. et al. Standard haemostatic tests following major obstetric haemorrhage. Int. J. Obstet. Anesth. 20, 135-141 (2011).
7. Theusinger, O. M. et al. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br. J. Anaesth. 106, 505-511 (2011).
8. Makino, S. et al. National survey of fibrinogen concentrate usage for post-partum hemorrhage in Japan: investigated by the Perinatology Committee, Japan Society of Obstetrics and Gynecology. J. Obstet. Gynaecol. Res. 41, 1155-1160 (2015).
9. Danes, A. F., Cuenca, L. G., Bueno, S. R., Mendarte Barrenechea, L. & Ronsano, J. B. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox. Sang. 94, 221-226 (2008).
10. Fenger-Eriksen, C., Lindberg-Larsen, M., Christensen, A. Q., Ingerslev, J. & Sorensen, B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br. J. Anaesth. 101, 769-773 (2008).
11. Gollop, N. D. et al. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfus. Med. 22, 350-355 (2012).
12. Thorarinsdottir, H. R. et al. Effects of fibrinogen concentrate administration during severe hemorrhage. Acta Anaesthesiol. Scand. 54, 1077-1082 (2010).
13. Weinkove, R. & Rangarajan, S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med. 18, 151-157 (2008).
14. Kikuchi, M. et al. Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. J. Obstet. Gynaecol. Res. 39, 770-776 (2013).
15. Wikkelso, A. J. et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br. J. Anaesth. 114, 623-633 (2015).
16. Santoso, J. T., Saunders, B. A. & Grosshart, K. Massive blood loss and transfusion in obstetrics and gynecology. Obstet. Gynecol. Surv. 60, 827-837 (2005).
17. Bell, S. F., Rayment, R., Collins, P. W. & Collis, R. E. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int. J. Obstet. Anesth. 19, 218-223 (2010).
18. Ahmed, S. et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage-an observational study. Transfus. Med. 22, 344-349 (2012).
19. Wikkelso, A. et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst. Rev. 8, CD008864 (2013).
20. Brenner, B. Haemostatic changes in pregnancy. Thromb. Res. 114, 409-414 (2004).
21. Wang, L. et al. Pre-delivery fibrinogen predicts adverse maternal or neonatal outcomes in patients with placental abruption. J. Obstet. Gynaecol. Res. 42, 796-802 (2016).
22. Pacheco, L. D., Saade, G. R., Costantine, M. M., Clark, S. L. & Hankins, G. D. An update on the use of massive transfusion protocols in obstetrics. Am. J. Obstet. Gynecol. 214, 340-344 (2016).
23. Stinger, H. K. et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J. Trauma. 64 (2 Suppl), S79-85 discussion S85 (2008).
24. Rossaint, R. et al. Management of bleeding following major trauma: an updated European guideline. Crit. Care. 14, R52 (2010).
25. Rossaint, R. et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit. Care. 20, 100 (2016).
26. Hiippala, S. T., Myllyla, G. J. & Vahtera, E. M. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth. Analg. 81, 360-365 (1995).
27. Honda, M. et al. Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report. J. Med. Case Rep. 8, 461 (2014).
28. Murphy, M. F. et al. Guidelines for the clinical use of red cell transfusions. Br. J. Haematol. 113, 24-31 (2001).
29. Ahonen, J., Stefanovic, V. & Lassila, R. Management of post-partum haemorrhage. Acta Anaesthesiol. Scand. 54, 1164-1178 (2010).
30. Mitra, B., Fitzgerald, M. & Chan, J. The utility of a shock index ≥ 1 as an indication for pre-hospital oxygen carrier administration in major trauma. Injury. 45, 61-65 (2014).
31. Popovsky, M. A. & Moore, S. B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 25, 573-577 (1985).